Shree Renuka Sugars’ board has approved an investment in its wholly-owned subsidiary, KBK Chem-Engineering, converting ₹573.65 million of loan into equity through a rights issue. The board also reviewed and approved the unaudited financial results for Q2 2026, with details available in the provided statement. The meeting took place on November 6, 2025, addressing both strategic investments and quarterly performance.
KBK Chem-Engineering Investment
Shree Renuka Sugars is set to bolster its subsidiary, KBK Chem-Engineering Private Limited, by converting debt into equity. The company will convert a loan of ₹573.65 million into equity through a rights issue, as of October 31, 2025. KBK is a wholly-owned subsidiary, and this move aims to strengthen its capital structure and reduce indebtedness. The conversion will result in fully paid-up equity shares of KBK at a face value of ₹100 each.
Q2 2026 Financial Results Highlights
The board also reviewed the unaudited standalone financial results for the quarter and half-year ended September 30, 2025. Key financial figures (in INR Million) from the standalone results include:
- Revenue from Operations: ₹23,881 for the quarter, ₹42,889 year-to-date.
- Total Income: ₹23,665 for the quarter, ₹42,839 year-to-date.
- Loss Before Tax: ₹(3,495) for the quarter, ₹(6,423) year-to-date.
- Net Loss for the period: ₹(3,188) for the quarter, ₹(5,339) year-to-date.
- Basic and Diluted EPS: ₹(1.50) for the quarter, ₹(2.51) year-to-date.
Consolidated Financial Results Overview
The consolidated results for the quarter ending September 30, 2025, present the following figures (in INR Million):
- Revenue from Operations: ₹24,865.
- Total Income: ₹24,603.
- Loss Before Tax: ₹(4,013).
- Net Loss for the period: ₹(3,693).
- Loss Attributable to equity holders of the parent: ₹(3,686).
- Basic and Diluted EPS: ₹(1.73).
This announcement confirms the company’s strategic focus on subsidiary support and provides an overview of its financial performance for the second quarter of the fiscal year 2026.
Source: BSE
